Prognostic Implication of Longitudinal Changes of Left Ventricular Global Strain After Chemotherapy in Cardiac Light Chain Amyloidosis.

cardiac amyloidosis cardiac organ response chemotherapy global longitudinal strain mortality

Journal

Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388

Informations de publication

Date de publication:
2022
Historique:
received: 26 03 2022
accepted: 06 06 2022
entrez: 11 7 2022
pubmed: 12 7 2022
medline: 12 7 2022
Statut: epublish

Résumé

Cardiac involvement is the main prognostic determinant in AL amyloidosis. We sought to determine the prognostic significance of longitudinal change of left ventricular (LV) global longitudinal strain (GLS) in cardiac light chain (AL) amyloidosis patients undergoing chemotherapy. We retrospectively investigated 117 cardiac AL amyloidosis patients who underwent chemotherapy from 2005 to 2019. All patients underwent comprehensive 2D conventional transthoracic echocardiography at baseline and after completion of first-line chemotherapy. Speckle tracking analysis of images was performed offline. Absolute value of LV GLS was expressed as [LV GLS] and change of [LV GLS] after chemotherapy was expressed as Δ [LV GLS]. Clinical outcomes including cardiac response and all-cause mortality were analyzed.Baseline clinical and echocardiographic parameters were similar in patients with and without CR. Δ [LV GLS] significantly differed between the CR and non-CR groups (0.4 ± 2.8% in the CR group vs. -0.6 ± 2.5% in the non-CR group, In cardiac amyloidosis patients who underwent chemotherapy, longitudinal change of [LV GLS] after chemotherapy showed significant association with overall survival as well as cardiac response.

Identifiants

pubmed: 35811735
doi: 10.3389/fcvm.2022.904878
pmc: PMC9263120
doi:

Types de publication

Journal Article

Langues

eng

Pagination

904878

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2022 Bak, Kim, Choi, Kim, Kim and Jeon.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Am Coll Cardiol. 2012 Nov 13;60(20):2074-81
pubmed: 23083779
Curr Cardiol Rep. 2019 Feb 12;21(2):7
pubmed: 30747298
Blood. 2010 Jul 29;116(4):522-8
pubmed: 20375312
JACC Cardiovasc Imaging. 2019 Jul;12(7 Pt 1):1165-1173
pubmed: 30121266
Amyloid. 2019;26(sup1):101-102
pubmed: 31343331
Blood. 2017 Apr 13;129(15):2111-2119
pubmed: 28126928
J Card Fail. 2008 Oct;14(8):687-94
pubmed: 18926441
Blood. 2019 Dec 19;134(25):2271-2280
pubmed: 31578202
J Am Soc Echocardiogr. 2018 Jan;31(1):64-70
pubmed: 29111123
J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14
pubmed: 25559473
JACC Cardiovasc Imaging. 2010 Apr;3(4):333-42
pubmed: 20394893
J Clin Oncol. 2012 Mar 20;30(9):989-95
pubmed: 22331953
Eur Heart J Cardiovasc Imaging. 2017 Sep 01;18(9):1057-1064
pubmed: 27965280
Br J Haematol. 2008 Nov;143(3):369-73
pubmed: 18691169
J Cardiol. 1991;21(2):391-401
pubmed: 1841926
J Clin Oncol. 2012 Dec 20;30(36):4541-9
pubmed: 23091105
Am J Hematol. 2015 Apr;90(4):E60-5
pubmed: 25580702
J Am Coll Cardiol. 1990 Nov;16(5):1135-41
pubmed: 2229760
J Clin Oncol. 2004 Sep 15;22(18):3751-7
pubmed: 15365071
Blood. 2013 Jun 27;121(26):5124-30
pubmed: 23670179
Sci Rep. 2019 May 23;9(1):7746
pubmed: 31123293
Circ Cardiovasc Imaging. 2010 May;3(3):249-56
pubmed: 20233858
Br J Haematol. 2013 Mar;160(5):582-98
pubmed: 23294331
Eur J Heart Fail. 2012 Oct;14(10):1121-9
pubmed: 22753861
J Clin Oncol. 2020 Oct 1;38(28):3252-3260
pubmed: 32730181
Eur Heart J Cardiovasc Imaging. 2014 Dec;15(12):1307-15
pubmed: 25190073
Sci Rep. 2019 Aug 21;9(1):12200
pubmed: 31434944
Circ Cardiovasc Imaging. 2015 Aug;8(8):
pubmed: 26259579
J Clin Oncol. 2013 Jul 20;31(21):2749-50
pubmed: 23775968
Circulation. 1991 Mar;83(3):808-16
pubmed: 1999031
JACC Cardiovasc Imaging. 2016 Feb;9(2):126-38
pubmed: 26777222
J Am Coll Cardiol. 2012 Sep 18;60(12):1067-76
pubmed: 22883634
J Am Soc Echocardiogr. 2016 Dec;29(12):1188-1196
pubmed: 28042785

Auteurs

Minjung Bak (M)

Division of Cardiology, Department of Medicine, Samsung Medical Center, Heart Vascular Stroke Institute, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Darae Kim (D)

Division of Cardiology, Department of Medicine, Samsung Medical Center, Heart Vascular Stroke Institute, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Jin-Oh Choi (JO)

Division of Cardiology, Department of Medicine, Samsung Medical Center, Heart Vascular Stroke Institute, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Kihyun Kim (K)

Divsion of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Seok Jin Kim (SJ)

Divsion of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Eun-Seok Jeon (ES)

Division of Cardiology, Department of Medicine, Samsung Medical Center, Heart Vascular Stroke Institute, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Classifications MeSH